Top of page
Global Site Navigation

School of Medical and Health Sciences

Local Section Navigation

Help us improve our content by rating this page.

Page rating system

Please leave a comment about your rating so we can better understand how we might improve the page.

You are here: Main Content

Professor Mel Ziman

Associate Dean

Contact Information Telephone: +61 8 6304 3640, Mobile: 0419 929 851, Email: m.ziman@ecu.edu.au, Campus: Joondalup, Room: JO21.513
Staff Member Details
Telephone: +61 8 6304 3640
Mobile: 0419 929 851
Facsimile: +61 8 6304 2626
Email: m.ziman@ecu.edu.au
Campus: Joondalup  
Room: JO21.513  

 

Mel is the Associate Dean (Research), School of Medical and Health Sciences, her areas of expertise include Melanoma and Huntington's disease. Mel is head of the ECU Melanoma Research Group. 

Current Teaching 

  • BSc Medical Science Honour Degree Coordination 
  • Postgraduate Supervision 

Background 

  • 2013-present: Professor, School of Medical and Health Sciences, ECU 
  • 2011-2013: Associate Professor, School of Medical Sciences, ECU 
  • 2005-2010: Associate Professor, School of Exercise, Biomedical and Health Science, ECU 
  • 2003-2005: Senior Lecturer, School of Exercise, Biomedical and Health Science, ECU 
  • 2001-2003: Lecturer, School of Exercise, Biomedical and Health Science, ECU 
  • 1996-2001: Senior Research Fellowship, School of Pathology and Laboratory Medicine, UWA 

Professional Associations

  • Society for Melanoma Research, USA 
  • ANZMTG 
  • Australian Neuroscience Society, 
  •  Human Genetics Society of Australia, 
  •  Australian Society for Medical Research 
  •  Australian and New Zealand Society of Development and Cell Biology 
  • Combined Biological Society 
  • International Society of Differentiation (ISD)

Awards and Recognition

University and National Teaching Awards

  • 2012: UniJobs Lecturer of the Year Award for the Top 10 Lecturers at ECU in 2011 
  • 2012: ECU award for Excellence in Postgraduate Supervision 
  • 2011: VC Excellence Award for Engagement in Research 
  • 2010: VC Citation for excellence in development of a Teaching and Research Nexus 
  • 2010: Citation for Outstanding Contribution to Student Learning – Australian Learning and Teaching 
  • 2008: VC Citation for excellence in development of a Teaching and Research Nexus 
  • 2008: Citation for Outstanding Contribution to Student Learning – Australian Learning and Teaching Council (Carrick) 
  • 2008: ECU Certificate of excellence in Learning and Teaching – UTEI over 85 
  • 2005: ECU award for Excellence in Postgraduate Supervision

Other 

  • 2010 - 2016: NHMRC grant review panel member 
  • 2009-2015: National OLT grant review panel member 
  • 2015: WAHTN Committee Member 
  • 2014: Parliamentary Standing Committee on Health - Skin cancer in Australia 
  • 2013: ASPIRE Professional Development Award, Perth Convention Bureau 
  • 2012- NHMRC Research Translation Faculty Member 

Research Areas and Interests 

  • The role of developmental genes in the proliferation, differentiation and migration of cells in the embryo and in disease processes such as cancer including Cutaneous Malignant Melanoma and neurodegenerative diseases including Huntington’s disease. 
  • Characterisation of circulating cells in Melanoma 
  •  Multidisciplinary therapy and neurogenesis in Huntington’s disease.

Qualifications

  • Bachelor of Science Honours, South Africa.
  • Degree of Doctor of Philosophy, South Africa, 1983.

Research

Recent Research Grants

  • Enabling Advanced Single Cell Cancer Genomics in Western Australia,  Cancer Research Trust,  The Grant,  2017 - 2022,  $305,925.
  • Liquid biopsy for personalised monitoring of melanoma patients ,  National Health and Medical Research Council,  Development Grants,  2017 - 2020,  $950,389.
  • A liquid biopsy to assist with staging of melanoma patients,  Perpetual Ltd,  IMPACT Philanthropy Application Program,  2017 - 2019,  $210,050.
  • Blood based biomarkers predictive of treatment efficacy in metastatic melanoma,  Spinnaker Health Research Foundation,  Collaborative Research Partnership Grants,  2017 - 2018,  $107,448.
  • Genetic Analysis of Blood Markers for Prognosis in Patients with Uveal Melanoma,  University of Western Australia,  Raine Foundation Grant,  2016 - 2018,  $100,000.
  • Circulating Tumour DNA to Predict and Monitor Treatment Response and Detect Acquired Resistance in Patients with Metastatic Melanoma,  Ramaciotti Foundation,  Grant,  2015 - 2018,  $99,911.
  • The effect of cognitive and exercise training on Brain Atrophy and Cognitive Decline in Breast Cancer Patients Treated with Adjuvant Chemotherapy Agents,  Cancer Council of WA Inc,  Collaborative Cancer Grant Scheme,  2018,  $49,966.
  • Understanding the Role of Melanoma Exosomes in Intercellular Communication,  Cancer Council of WA Inc,  Collaborative Cancer Grant Scheme,  2017 - 2018,  $43,230.
  • Predictive significance of circulating tumour cells (CTCs), circulating tumour DNA (ctDNA) and serum vascular endothelial growth factor (VEGF) in advanced melanoma patients treated with pembrolizumab,  Merck Sharp and Dohme (Australia) Pty Ltd,  Grant,  2016 - 2018,  $73,300.
  • Medical and Health Research Infrastructure Fund 2016 (Round 20),  Department of Health WA,  Medical and Health Research Infrastructure,  2017 - 2018,  $13,910.
  • Blood Based Biomarkers Predictive of Treatment Response in Melanoma,  Cancer Council of WA Inc,  Grant,  2016 - 2018,  $246,822.
  • A Blood Based `Liquid Biopsy? to Improve Healthcare for Metastatic Melanoma Patients,  Department of Health WA,  SHRAC Research Translation Projects,  2016 - 2018,  $4,075,030.
  • Translation of the HEROs Program of Multidisciplinary Therapy for Patients with Huntington s Disease (HD) into community settings,  Edith Cowan University,  ECU Industry Collaboration Scheme - 2016 Open Round,  2017 - 2018,  $169,003.
  • The effect of multidisciplinary therapy on neurodegeneration and clinical decline in Huntington?s disease individuals before the onset of diagnosable symptoms.,  Edith Cowan University,  ECU Early Career Researcher Grant - 2016,  2016 - 2017,  $27,900.
  • Circulating Melanoma Cells as Predictive Biomarkers of Treatment Response and Disease Status,  Cancer Council of WA Inc,  Grant,  2015 - 2017,  $111,519.
  • Circulating Tumour Cells (CTCs) as biomarkers in metastatic melanoma,  Edith Cowan University,  ECU Early Career Researcher Grant - 2016,  2016 - 2017,  $30,000.
  • HEROs Huntington's disease Exercise Rehabilitation Optimisation Study,  Lotterywest,  Grant,  2014 - 2017,  $780,974.
  • Using a Functional Protein Array to Identify Autoantibody Biomarkers with Diagnostic Potential for Melanoma,  National Health and Medical Research Council,  Development Grants,  2014 - 2017,  $778,368.
  • Gene expression profiling of circulating tumour cells (CTCs) isolated from metastatic melanoma patients using a microfluidic chip,  Cancer Council of WA Inc,  Grant - Early Career Investigator,  2016 - 2017,  $35,000.
  • Medical and Health Research Infrastructure Fund (MHRIF) 2015 (Round 19),  Department of Health WA,  Medical and Health Research Infrastructure,  2016 - 2017,  $18,590.
  • Western Australia Single-Cell Isolation and Genomics Preparation Facility,  Australian Research Council,  Grant - Linkage (Infrastructure),  2017,  $430,000.
  • A preliminary study investigating blood markers of response to treatment with immune system targeted therapy in advanced melanoma,  Cancer Council of WA Inc,  Grant - Early Career Investigator,  2015 - 2017,  $35,000.
  • A Single-Molecule Super-Resolution Microscopy Facility in Western Australia,  Australian Research Council,  Grant - Linkage (Infrastructure),  2016,  $2,094,000.
  • PAX3 dysregulation in glioblastoma.,  Edith Cowan University,  ECU Early Career Researcher Grant - 2015,  2015 - 2016,  $22,800.
  • Mass Cytometry: A breakthrough in multidimensional systems biology,  Australian Research Council,  Grant - Linkage (Infrastructure),  2015 - 2016,  $1,081,489.
  • Transcriptomic profiling of Circulating Tumour Cells (CTCs) isolated from metastatic melanoma patients,  Edith Cowan University,  School of Medical and Health Sciences Research Grant Scheme 2016,  2016,  $10,000.
  • Circulating Tumour Cells (CTCs) as a diagnostic tool to monitor disease progression in melanoma patients,  Edith Cowan University,  ECU Industry Collaboration Grant - 2015 (Round 1),  2015 - 2016,  $137,227.
  • 2015 NHMRC Equipment Grant,  National Health and Medical Research Council,  Equipment Grant 2015,  2015 - 2016,  $6,798.
  • Melanoma Mutation Profiling For Personalised Treatment,  National Health and Medical Research Council,  Project Grants,  2013 - 2016,  $765,359.
  • The role of DACH1 and the mir-200 family in medulloblastoma pathogenesis,  Cancer Council of WA Inc,  Cancer Council, Scholarship,  2014 - 2015,  $2,000.
  • In-Vivo Multispectral and X-Ray Micro-CT Imaging: Founding a Western Australian Small Animal Imaging Core Facility,  Australian Research Council,  Grant - Linkage (Infrastructure),  2010 - 2015,  $1,484,000.
  • 2014 NHMRC Equipment Grant Rob Newton and Mel Ziman,  National Health and Medical Research Council,  Equipment Grant 2014,  2014 - 2015,  $9,336.
  • Genetic Analysis of Melanoma Cells in Blood For Personalised Treatment Management,  Edith Cowan University,  ECU Early Career Researcher Grant - 2013,  2013 - 2014,  $24,083.
  • The Transcriptional profile of a metastatic circulation melanoma cell,  National Health and Medical Research Council,  Project Grants,  2011 - 2014,  $264,182.
  • Standard Equipment Grant 2012,  National Health and Medical Research Council,  Equipment Grant 2012,  2012 - 2014,  $5,744.
  • PAX3-mediated melanocytic response to environmental factors,  Edith Cowan University,  ECU Early Career Researcher Grant - 2013,  2013 - 2014,  $25,000.
  • Detection of Vemurafenib Resistance in Circulating Tumour Cells for Personalised Treatment of Melanoma,  Harry Perkins Institute of Medical Research,  Scott Kirkbride Melanoma Research Centre - Discovery Research Priming Grant,  2013 - 2014,  $68,182.
  • The role of DACH1 and the mir-200 family in medulloblastoma pathogenesis,  Telethon Kids Institute,  Honours Telethon Adventurers Children's Brain Cancer Training Award,  2014,  $4,000.
  • Expanding Capacity and Capability in Western Australian Flow Cytometry for Earth, Oceans, Environmental and Biomedical Science: State-of-the-Art Four Laser and 12 Colour Analysis,  Australian Research Council,  Grant - Linkage (Infrastructure),  2012 - 2013,  $598,000.
  • Detection of stem cell markers expression in circulating melanoma cells using multiparameter flow cytometry as a prognosis tool,  Edith Cowan University,  ECU Early Career Researcher Grant - 2012 (Round 1),  2012 - 2013,  $19,480.
  • The effects of environmental enrichment on physiological markers of disease progression in patients with Huntington?s disease.,  Edith Cowan University,  ECU Early Career Researcher Grant - 2012 (Round 1),  2012 - 2013,  $24,568.
  • The Effects of Environmental Enrichment on Clinical Measures of Disease Progression and Quality of Life for Patients with Huntington's Disease,  Huntington's WA (Inc),  Lotterywest Grant,  2010 - 2013,  $530,317.
  • Neon Transfection System and Biomedical Research Grade -30oC Freezer for Alzheimer?s and Melanoma Research,  National Health and Medical Research Council,  Equipment Grant 2011,  2011 - 2012,  $10,927.
  • The association between environmental stresses (UV, heat and chemicals) and melanoma incidence amongst staff at Telfer Gold Mine,  Edith Cowan University,  ECU Industry Collaboration - Grant,  2011 - 2012,  $158,456.
  • A high-throughput protein production and structure facility,  Australian Research Council,  Grant - Linkage (Infrastructure),  2012,  $470,000.
  • Nano mechanical analysis of metastactic melanoma cancer cells using atomic force microscopy,  Cancer Council of WA Inc,  Cancer Council, Scholarship,  2012,  $7,500.
  • The Use of Circulating Melanoma Cells to monitor Treatment Efficacy in Patients with Cutaneous Malignant Melanoma,  University of Western Australia,  Grant - CaPCREU,  2010 - 2011,  $17,240.
  • Patient outcome affected by paramedic pre hospital treatment of patients with severe brain injuries,  Edith Cowan University,  ECU Industry Collaboration - Grant,  2007 - 2011,  $174,837.
  • Evaluation of Paramedic Treatment Techniques to Assess Contributing Factors to Mortality in the Pre Hospital Management of Traumatic Brain Injury,  Edith Cowan University,  ECU Industry Collaboration - Grant,  2009 - 2011,  $54,800.
  • Nature's Wonder,  Cocky Smart,  Grant,  2010 - 2011,  $125,023.
  • CCD Camera for Inverted Fluorescent Microscope in Alzheimer's and Melanoma Research,  National Health and Medical Research Council,  Equipment Grant,  2010 - 2011,  $10,881.
  • A Western Australian Core Cell Sorting Facility - Ultra-Small Objects and Rare Cell Populations,  Australian Research Council,  Grant - Linkage (Infrastructure),  2009 - 2010,  $524,000.
  • Isolation and Characterisation of Melanoma Cancer Stem Cells,  Edith Cowan University,  ECU Early Career Researcher - Grant,  2008 - 2010,  $24,975.
  • Characterisation and Quantification of Circulating Melanoma Cells,  Cancer Council of WA Inc,  Cancer Council, Scholarship,  2010,  $3,000.
  • Neurological cell replacement therapies: improving outcomes by matching developmental profiles of transplanted cells with the damaged brain area. ,  Australian Research Council,  Grant - Discovery Projects,  2007 - 2010,  $118,176.
  • Detection and Characterisation of Circulating Cutaneous Malignant Melanoma Cells,  Edith Cowan University,  ECU Industry Collaboration - Grant,  2009 - 2010,  $288,403.
  • Quantification and Characterisation of Circulating Cutaneous Malignant Melanoma Cells,  Cancer Council of WA Inc,  Grant,  2009,  $70,000.
  • Development of a Blood Test for Cutaneous Malignant Melanoma,  Edith Cowan University Foundation,  Donation,  2007 - 2008,  $34,485.
  • Detection of Migrating Melanoma Cells in Peripheral Blood of Patients with Metastatic Melanoma,  Cancer Council of WA Inc,  Grant,  2007 - 2008,  $2,000.
  • Development of a blood test for Cutaneous Malignant Melanoma,  Edith Cowan University,  ECU Industry Collaboration - Grant,  2007 - 2008,  $115,019.
  • A cryopreparation facility for Western Australia,  Australian Research Council,  Grant - Linkage (Infrastructure),  2008,  $485,000.
  • Developmental genes and Melanoma detection,  Edith Cowan University,  ECU Industry Collaboration - Grant,  2005 - 2008,  $69,400.
  • Matching the developmental transcription factor profiles of transplanted cells and host injured brain regions is crucial for successful cell transplant therapies,  Harry Perkins Institute of Medical Research,  Grant,  2005 - 2006,  $60,000.
  • Corbett Research 'RotorGene' 2 channel real-time DNA multiplexing system,  Ramaciotti Foundation,  Grant,  2004 - 2005,  $49,000.

Recent Publications (within the last five years)

Book Chapters

  • Freeman, J., Gray, E., Ziman, M., (2015), Circulating Tumor Cells as Biomarkers in Cancer. Biomarkers in Cancer, 31-51, London, UK, Springer, DOI: 10.1007/978-94-007-7681-4_21.
  • Ziman, M., Millward, M., Pearce, R., Lee, M., (2012), Serological Biomarkers in Melanoma. Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Melanoma, 195-208, USA, Humana Press, DOI: 10.1007/978-1-60761-433-3_15.

Journal Articles

  • Calapre, L., Warburton, L., Millward, M., Ziman, M., Gray, E., (2017), Circulating tumour DNA (ctDNA) as a liquid biopsy for melanoma. Cancer Letters, 404(28 Sept, 2017), 62-69, Ireland, Elsevier, DOI: 10.1016/j.canlet.2017.06.030.
  • McEvoy, A., Calapre, L., Pereira, M., Giardina, T., Robinson, C., Khattak, M., Meniawy, T., Pritchard, A., Hayward, N., Amanuel, B., Millward, M., Ziman, M., Gray, E., (2017), Sensitive droplet digital PCR method for detection of TERT promoter mutations in cell free DNA from patients with metastatic melanoma. Oncotarget, In Press(In Press), 11p., United States, Impact Journals LLC.
  • Aya-Bonilla, C., Marsavela, G., Freeman, J., Lomma, C., Frank, M., Khattak, M., Tarek, M., Millward, M., Warkiani, M., Gray, E., Ziman, M., (2017), Isolation and detection of circulating tumour cells from metastatic melanoma patients using a slanted spiral microfluidic device. Oncotarget, In Press(In Press), 15p..
  • Calapre, L., Gray, E., Kurdykowski, S., David, A., Descargues, P., Ziman, M., (2017), SIRT1 activation mediates heat-induced survival of UVB damaged Keratinocytes. BMC Dermatology, 17(8), Article Number: 8, BioMed Central, DOI: 10.1186/s12895-017-0060-y.
  • Bartlett, D., Cruickshank, T., Hannan, A., Eastwood, P., Lazar, A., Ziman, M., (2016), Neuroendocrine and neurotrophic signaling in Huntington's Disease: Implications for pathogenic mechanisms and treatment strategies. Neuroscience and Biobehavioral Reviews, 71(2016), 444-454, Elsevier Ltd, DOI: 10.1016/j.neubiorev.2016.09.006.
  • Calapre, L., Gray, E., Kurdykowski, S., David, A., Hart, P., Descargues, P., Ziman, M., (2016), Heat-mediated reduction of apoptosis in UVB-damaged keratinocytes in vitro and in human skin ex vivo. BMC Dermatology, 16(1), Article no. 6, London, UK, BioMed Central Ltd., DOI: 10.1186/s12895-016-0043-4.
  • Phan, T., Carter, O., Adams, C., Waterer, G., Chung, L., Hawkins, M., Rudd, C., Ziman, M., Strobel, N., (2016), Discriminant validity of the Hospital Anxiety and Depression Scale, Beck Depression Inventory (II) and Beck Anxiety Inventory to confirmed clinical diagnosis of depression and anxiety in patients with chronic obstructive pulmonary disease. Chronic Respiratory Disease, 13(3), 220-228, London, UK, Sage Publications Ltd., DOI: 10.1177/1479972316634604.
  • Zaenker, P., Gray, E., Ziman, M., (2016), Autoantibody Production in Cancer?The Humoral Immune Response toward Autologous Antigens in Cancer Patients. Autoimmunity Reviews, 15(5), 477-483, Elsevier, DOI: 10.1016/j.autrev.2016.01.017.
  • Cruickshank, T., Reyes, A., Ziman, M., (2015), A systematic review and meta-analysis of strength training in individuals with Multiple Sclerosis or Parkinson disease. Medicine, 94(4), e411, Wolters Kluwer Health, DOI: 10.1097/MD.0000000000000411.
  • Gray, E., Reid, A., Bowyer, S., Calapre, L., Siew, K., Pearce, R., Cowell, L., Frank, M., Millward, M., Ziman, M., (2015), Circulating Melanoma Cell Subpopulations: Their Heterogeneity and Differential Responses to Treatment. Journal of Investigative Dermatology, 135(8), 2040-2048, London, United Kingdom, Nature Publishing Group, DOI: 10.1038/jid.2015.127.
  • Reid, A., Freeman, J., Millward, M., Ziman, M., Gray, E., (2015), Detection of BRAF-V600E and V600K in melanoma circulating tumour cells by droplet digital PCR. Clinical Biochemistry, 48(15), 999-1002, Philadelphia, USA, Elsevier, DOI: 10.1016/j.clinbiochem.2014.12.007.
  • Gray, E., Rizos, H., Reid, A., Boyd, S., Pereira, M., Lo, J., Tembe, V., Freeman, J., Lee, J., Scolyer, R., Siew, K., Lomma, C., Cooper, A., Khattak, M., Meniawy, T., Long, G., Carlino, M., Millward, M., Ziman, M., (2015), Circulating tumor DNA to monitor treatment response and detect acquired resistance in patients with metastatic melanoma. Oncotarget, 6(39), 42008-42018, New York, USA, Impact Journals LLC, DOI: 10.18632/oncotarget.5788.
  • Bartlett, D., Boyle, GM., Ziman, M., Medic, S., (2015), Mechanisms contributing to differential regulation of PAX3 downstream target genes in normal human epidermal melanocytes versus melanoma cells. PLoS One, 10(4), Article no. e0124154, San Francisco, USA, Public Library of Science, DOI: 10.1371/journal.pone.0124154.
  • Reyes, A., Cruickshank, T., Nosaka, K., Ziman, M., (2015), Respiratory muscle training on pulmonary and swallowing function in patients with Huntington's disease: A pilot randomised controlled trial. Clinical Rehabilitation, 29(10), 961-973, SAGE Publications Ltd, DOI: 10.1177/0269215514564087.
  • Collins, L., Begeti, F., Panin, F., Lazar, A., Cruickshank, T., Ziman, M., Mason, S., Barker, R., (2015), Novel Nut and Bolt Task Quantifies Motor Deficits in Premanifest and Manifest Huntington?s Disease. PLoS Currents, 7(Huntington Disease), online, San Francisco, USA, Public Library of Science, DOI: 10.1371/currents.hd.ded251617ae62a1364506b0521bd3761.
  • Cruickshank, T., Thompson, J., Dominguez , J., Reyes, A., Bynevelt, M., Georgiou-Karistianis, N., Barker, R., Ziman, M., (2015), The effect of multidisciplinary rehabilitation on brain structure and cognition in Huntington's disease: an exploratory study. Brain and Behavior, 5(2), 1-10, West Sussex, UK, John Wiley and Sons Ltd, DOI: 10.1002/brb3.312.
  • Blake, J., Ziman, M., (2014), Pax genes: regulators of lineage specification and progenitor cell maintenance. Development, 141(4), 737-751, United Kingdom, The Company of Biologists Ltd, DOI: 10.1242/dev.091785.
  • Reyes, A., Cruickshank, T., Ziman, M., Nosaka, K., (2014), Pulmonary function in patients with Huntington's Disease. BMC Pulmonary Medicine, 14(1), Article No. 89, BioMed Central Ltd, DOI: 10.1186/1471-2466-14-89.
  • Fyfe, G., Fyfe, S., Meyer, J., Ziman, M., Sanders, K., Hill, J., (2014), Students reflecting on test performance and feedback: An on-line approach. Assessment and Evaluation in Higher Education, 39(2), 179-194, Routledge, DOI: 10.1080/02602938.2013.801063.
  • Klinac, D., Gray, E., Freeman, J., Reid, A., Bowyer, S., Millward, M., Ziman, M., (2014), Monitoring changes in circulating tumour cells as a prognostic indicator of overall survival and treatment response in patients with metastatic melanoma. BMC Cancer, 14(1), Article number 423, United Kingdom, BioMed Central Ltd, DOI: 10.1186/1471-2407-14-423.
  • Cruickshank, T., Reyes, A., Penailillo, L., Thompson, J., Ziman, M., (2014), Factors that contribute to balance and mobility impairments in individuals with Huntington's disease. Basal Ganglia, 4(2), 67-70, Netherlands, Elsevier, DOI: 10.1016/j.baga.2014.04.002.
  • Reyes, A., Cruickshank, T., Thompson, J., Ziman, M., Nosaka, K., (2014), Surface electromyography activity of submental muscles during swallowing and expiratory muscle training tasks of Huntington?s disease patients. Journal of Electromyography and Kinesiology, Online(Online), 153-158, United Kingdom, Elsevier, DOI: org/10.1016/j.jelekin.2013.09.009.
  • Dye, DE., Medic, S., Ziman, M., Coombe, DR., (2013), Melanoma Biomolecules: Independently Identified but Functionally Intertwined. Frontiers in Oncology, 3 Sep(2013), Article No 252, Frontiers in Oncology online, Frontiers Research Foundation.
  • Reyes, A., Ziman, M., Nosaka, K., (2013), Respiratory muscle training for respiratory deficits in neurodegenerative disorders: a systematic review. Chest , 143(5), 1386-1394, American College of Chest Physicians, DOI: 10.1378/chest.12-1442.
  • Calapre, L., Gray, E., Ziman, M., (2013), Heat stress: a risk factor for skin carcinogenesis. Cancer Letters, 337(1), 35-40, Ireland, Elsevier Ireland Ltd.
  • Klinac, D., Gray, E., Milward, M., Ziman, M., (2013), Advances in personalized targeted treatment of metastatic melanoma and non-invasive tumor monitoring. Frontiers in Oncology, 3(March 2013), Article 00054, DOI: 10.3389/fonc.2013.00054.
  • Zaenker, P., Ziman, M., (2013), Serological Autoantibodies as Diagnostic Cancer Biomarkers - A Review. Cancer Epidemiology Biomarkers and Prevention , 22(12), 2161-81, USA, American Association for Cancer Research, DOI: 10.1158/1055-9965.EPI-13-0621..
  • Blake, J., Ziman, M., (2013), The Characterisation of Pax3 Expressant Cells in Adult Peripheral Nerve. PLoS One, 8(3), e59184, USA, Public Library of Science, DOI: 10.1371/journal.pone.0059184.
  • Reid, A., Millward, M., Pearce, R., Lee, M., Frank, M., Ireland, A., Monshizadeh, L., Rai, T., Heenan, P., Medic, S., Kumarasinghe, P., Ziman, M., (2013), Markers of circulating tumour cells in the peripheral blood of patients with melanoma correlate with disease recurrence and progression. British Journal of Dermatology, 168(1), 85-92, Wiley, DOI: 10.1111/bjd.12057.
  • Thompson, J., Cruickshank, T., Penailillo, L., Lee, J., Newton, R., Barker, R., Ziman, M., (2013), The effects of multidisciplinary rehabilitation in patients with early-to-middle-stage Huntington's disease: a pilot study. European Journal of Neurology, 20(9), 1325-1329, DOI: 10.1111/ene.12053.
  • Charytonowicz, E., Matushansky, I., Castillo-Martin, M., Ladanyi, M., Cordon-Cardo, C., Domingo-Domenech, J., Ziman, M., (2012), PAX7-FKHR fusion gene inhibits myogenic differentiation via NF-kappaB upregulation. Clinical and Translational Oncology, 14(3), 197-206, DOI: 10.1007/s12094-012-0784-4.
  • Freeman, J., Gray, E., Milward, M., Pearce, R., Ziman, M., (2012), Evaluation of a multi-marker immunomagnetic enrichment assay for the quantification of circulating melanoma cells. Journal of Translational Medicine, 10(1), art. no. 192 , United Kingdom, Biomed Central, DOI: 10.1186/1479-5876-10-192.

Conference Publications

  • Maurya, D., Fooladvand, M., Gray, E., Ziman, M., Alameh, K., (2015), Lab-on-chip platform for circulating tumor cells isolation. Micro+Nano Materials, Devices, and Systems, 9668(6-9 Dec, 2015), 9668-34, Sydney, Australia, SPIE.

Research Student Supervision

Principal Supervisor

  • Doctor of Philosophy,  New Perspectives On Melanoma: The Role Of Pax3
  • Master of Science (Human Biology),  Pax3 And Cutaneous Malignant Melanoma
  • Master of Science (Human Biology),  The Effectiveness Of Airway Management In The Pre Hospital Treatment Of Traumatic Brain Injury
  • Master of Science (Human Biology),  The Identification Of Diagnostic Serological Autoantibodies For Cutaneous Melanoma.
  • Doctor of Philosophy,  An Investigation Of The Mechanism Of Pax7 Mediated Oncogenesis Via In Silico Biology.
  • Master of Science (Human Biology),  Pax3 Expression, Protein Modifications And Downstream Target Gene Profiling In Melanocytes And Melanoma Cells
  • Doctor of Philosophy,  The Role Of Pax3/pax7-fkhr In Mesenchymal Stem Cell Myogenic Differentiation And Rhabdomyosarcomagenesis.
  • Doctor of Philosophy,  New Perspectives On Melanoma: The Role Of Pax3
  • Master of Science (Human Biology),  Pax3 And Cutaneous Malignant Melanoma
  • Doctor of Philosophy,  Pulmonary And Swallowing Function In Patients With Huntington's Disease.
  • Doctor of Philosophy,  The Clinical Utility Of Multidisciplinary Rehabilitation In Individuals With Huntington's Disease
  • Doctor of Philosophy,  Heat Stress: A Risk Factor For Skin Carcinogenesis
  • Master of Science (Human Biology),  Molecular Genetic Investigation Of Autosomal Dominant Hemifacial Microsomia.
  • Doctor of Philosophy,  The Developmental Function Of Pax 7: Chromatin-immunoprecipitation Discovery Of Pax7 Target Genes
  • Master of Science (Human Biology),  The Efficacy Of Inhaled Methoxyflurance And Intranasal Fentanyl For The Pre Hospital Management Of Cardiac Or Visceral Pain.
  • Doctor of Philosophy,  The Characterisation Of Pax3 Expressant Cells In Adult Peripheral Nerve
  • Master of Science (Human Biology),  The Role Of Pax3 In The Metastasis Of Cutaneous Malignant Melanoma.
  • A Possible Role For Pax7 In Initiating Differentiation Of Neuronal Cells In The Optic Tectum During Normal Development And After Injury
  • The Role Of Pax3 And Pax7 In Alveolar Rhabdomyosarcoma Focusing On Dna Binding Domains, Alternative Splicing And Target Gene Analysis By Microarray
  • Master of Science (Human Biology),  Optimisation Of The Isolation And Identification Of Circulating Melanoma Cells
  • Doctor of Philosophy,  The Role Of Pax7 In The Formation Of The Superior Colliculus And The Vertebrate Visual System.

Co-principal Supervisor

  • Master of Science (Human Biology),  The Evaluation Of Midazolam On Head Injured Patients In The Prehospital Setting
  • Master of Science (Human Biology),  Genetic Markers In Circulating Tumour Cells As A Measure Of The Metastatic Propensity Of Uveal Melanoma
Skip to top of page